Snowball logo
logo
BCLI

Brainstorm Cell Therapeutics Inc

BCLI NASDAQ
$0.71+$0.01  (1.43%)

Frequently asked questions

What sector does Brainstorm Cell Therapeutics Inc (BCLI) operate in?

Brainstorm Cell Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Brainstorm Cell Therapeutics Inc (BCLI) current stock price?

As of the latest data, Brainstorm Cell Therapeutics Inc stock price is $0.71, with a previous close of $0.70. Brainstorm Cell Therapeutics Inc gained $0.01 in the last trading session, representing a 1.43% increase.

What is Brainstorm Cell Therapeutics Inc (BCLI) current market capitalization?

Brainstorm Cell Therapeutics Inc market cap is approximately 7.83 million.

What is Brainstorm Cell Therapeutics Inc (BCLI) Earnings Per Share (EPS)?

The trailing EPS is -$1.42, and the forward EPS is -$1.07.

What is Brainstorm Cell Therapeutics Inc (BCLI) EBITDA?

Brainstorm Cell Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -2.00 million.

Does Brainstorm Cell Therapeutics Inc (BCLI) pay dividends?

No. Brainstorm Cell Therapeutics Inc does not pay a dividend.

What is Brainstorm Cell Therapeutics Inc (BCLI) beta (volatility) score?

Brainstorm Cell Therapeutics Inc has a beta of 0.581, indicating lower volatility than the overall market.